Clinical Trials Directory

Trials / Completed

CompletedNCT01288924

Can Parecoxib Reduce Post-operative Ipsilateral Shoulder Pain?

Can Preemptive Analgesia With Parecoxib Reduce Post-operative Ipsilateral Shoulder Pain? A Double-blinded, Randomized, Placebo-controlled Trial.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
160 (actual)
Sponsor
Chiang Mai University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the efficacy of parecoxib with placebo on the incidence and severity of postthoracotomy shoulder pain, the amount of analgesic requirement for relieving severity of postthoracotomy shoulder pain and adverse events associated with treatment.

Detailed description

The incidence of Post-operative Ipsilateral Shoulder Pain (PISP) varies from 21-97% after thoracic surgery, despite receiving effective thoracic epidural analgesia. This pain has been described as constant, aching in quality, unrelated to position change or respiration. Possible causes of shoulder pain includes injury of the phrenic nerve, the lateral decubitus position, transection of major bronchus or preexisting arthritis condition. The possibilities of prevention and management of PISP are taken into consideration. Thoracic epidural block will be performed in all patients before general anesthesia.

Conditions

Interventions

TypeNameDescription
DRUGParecoxibParecoxib 40 mg intravenous before surgery and every 12 hours for two days.
OTHERControlNSS 2 ml intravenous before surgery and every 12 hours for two days.

Timeline

Start date
2011-02-01
Primary completion
2015-10-01
Completion
2016-01-01
First posted
2011-02-03
Last updated
2016-12-06

Locations

2 sites across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01288924. Inclusion in this directory is not an endorsement.